您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Compstatin TFA
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Compstatin TFA
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
规格:98%
分子量:1664.79
包装与价格:
包装价格(元)
1mg电议
5mg电议

产品介绍
CompstatinTFA是一个13残基环肽,是补体系统C3的有效抑制剂,具有物种特异性。CompstatinTFA结合到狒狒的C3,并对狒狒血液中的蛋白水解裂解具有抗性(类似人类)。CompstatinTFA只抑制灵长类补体系统的激活。CompstatinTFA对补体经典途径和旁路途径的IC50值分别为63μM和12μM。
货号:ajcx31836
CAS:N/A
分子式:C68H100F3N23O19S2
分子量:1664.79
溶解度:DMSO: 110 mg/mL (66.07 mM); H2O: 5.22 mg/mL (3.14 mM)
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Compstatin TFA, a 13-residue cyclic peptide, is a potent inhibitor of the complement system C3 with species specificity. Compstatin TFA binds to baboon C3 and is resistant to proteolytic cleavage in baboon blood (similar to humans). Compstatin TFA inhibits only the activation of primates' complement system. Compstatin TFA exhibits IC50 values of 63 μM and 12 μM for classical and alterative complement pathway, respectively[1][2][3].

Compstatin exhibits an in vitro half-life in human blood of about 2 hr[2].In solution, compstatin forms a β-turn at residues Gln-5-Gly-8 with the disulfide bridge Cys-2-Cys12, residues Ile-1-Val-4, and Thr-13, forming a hydrophobic cluster[3].

Compstatin (21 mg/kg) produces complete inhibition when given as a combination of bolus injection and infusion. Compstatin completely inhibits in vivo heparin/protamine-induced complement activation without adverse effects on heart rate or systemic arterial, central venous, and pulmonary arterial pressures[1].Compstatin is stable in baboon plasma for more than 24 h[1].Pig xenografts survival is significantly longer in the Compstatin perfused group than in the control group[2]. Animal Model: Juvenile baboons (P. Anubis) weighing 10.5-28.8 kg[1].

[1]. Soulika AM, et al. Inhibition of heparin/protamine complex-induced complement activation by Compstatin in baboons. Clin Immunol. 2000 Sep;96(3):212-21. [2]. Fiane AE, et al. Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts. Xenotransplantation. 1999 Feb;6(1):52-65. [3]. Bert J C Janssen, et al. Structure of compstatin in complex with complement component C3c reveals a new mechanism of complement inhibition. J Biol Chem. 2007 Oct 5;282(40):29241-7. [4]. A Sahu, et al. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. J Immunol. 1996 Jul 15;157(2):884-91.